Research
David M. Center, MD, Nuclear factors associated with control of the CD4+ T cell cycle; functions of pro-Interleukin-16 and its dysregulation in T cell leukemias; effects of Interleukin 16 stimulation of CD4+ T cells
John H. Connor, PhD, Protein synthesis in virus replication.
Ronald B. Corley, PhD, B lymphocyte development and differentiation; antibody assembly, trafficking, and secretion
William Cruikshank, PhD, Characterization, process of synthesis and secretion, and clinical relevance to inflammation of the CD4+ T-cell-specific cytokine interleukin 16 (IL-16)
Gerald Denis, PhD, Effect of the novel transcriptional co-activator, Brd2 in hematological malignancies and obesity
Douglas V. Faller, MD, PhD, Effects of oncogenes on signal transduction, cellular growth and differentiation, apoptosis, and the cellular immune system
Rachel Fearns, PhD, Host Pathogen interactions; virus molecular biology
Lisa Ganley-Leal, PhD, Defining immune correlates of protection in human schistosomiasis
Caroline A. Genco, PhD, Microbial pathogenesis, vaccine development, host- parasite interactions, and bacterial gene regulation
Rahm Gummuluru, PhD, Molecular mechanisms of human immunodeficiency virus (HIV), dendritic cell interactions
Andrew J. Henderson, PhD, Molecular events that regulate HIV expression
Robin Ingalls, MD, Reproductive immunology and the pathogenesis of gonococcal and chlamydia infections
Robert Lafyatis, MD, Fibrosis and autoimmunity in systemic sclerosis
Adam Lerner, MD, Lymphoid malignancies and the role of focal-adhesion-associated proteins in breast cancer anti-estrogen resistance
Joseph P. Mizgerd, ScD, Acute lower respiratory tract infection, cytokines, innate immunity, neutrophil recruitment and activation, pneumonia, transcriptional and post-transcriptional regulation of gene expression
Gustavo Mostoslavsky, MD, PhD, Stem cell biology and gene therapy
Elke Mühlberger, PhD, Host response to filovirus infection, molecular mechanisms of filovirus replication and transcription
John R. Murphy, PhD, Structure of the diphtheria toxin repressor; diphtheria toxin catalytic domain and entry into the eukaryotic cell cytosol; structure- function of IL7
Barbara S. Nikolajczyk, PhD, Inflammation in type 2 diabetes and other inflammatory diseases; molecular mechanisms of disease pathogenesis; regulation of IL-1 beta production
Daniel G. Remick, MD, Sepsis, asthma, regulation of ongoing inflammation
Ian Rifkin, MD, PhD, Mechanisms responsible for the pathogenesis of systemic lupus erythematosus and lupus-associated atherosclerosis
Jennifer Schlezinger, PhD, Immunotoxicology, aryl hydrocarbon receptor and peroxisome proliferators activated receptor-g
David C. Seldin, MD, PhD, Lymphoproliferative diseases and other malignancies; mechanisms of disease in the plasma cell disorder “systemic amyloidosis”
Jacqueline Sharon, PhD, Generation and characterization of polyclonal antibody libraries for the treatment and diagnosis of cancer and infectious diseases
David H. Sherr, PhD, Cancer immunotherapy; The role of the environmental chemical receptor (AhR) in regulatory T cell development; Mechanisms of immunosuppression mediated by environmental pollutants; The role of the AhR in breast cancer
Andrew Taylor, PhD, Immunprivilege in the eye; neuropeptides as inhibitors of immune responses; regulatory T cells
Gregory A. Viglianti, PhD, Molecular biology of HIV-1; the role of virus-host cell interactions in pathogenesis
Lee M. Wetzler, MD, Vaccine development; microbial immunity and pathogenesis; effect of bacterial products on eukaryotic cells
